Author: Hoff Communications
MRI Access Program
The MRI Access Fund assists financially challenged individuals requiring a cranial magnetic resonance imaging (MRI) exam for MS diagnosis or disease evaluation.
Read News ArticleIbudilast Receives Fast Track Designation from FDA
MediciNova, Inc., the biopharmaceutical company developing ibudilast (MN-166), announced that this investigational medication for progressive forms of MS has received Fast Track designation from the United States Food and Drug Administration (FDA). This designation is intended for drugs under development for treating serious diseases and with the potential to address unmet medical needs for such diseases.
Read News ArticleSpread the Word
Three books from MSAA’s free Lending Library are featured.
Read News ArticleThe Motivator 2012 Archives
The 2012 Motivator Archives: MSAA’s 48-plus page magazine highlights and explains many vital issues of importance to our readers affected by MS.
Read News ArticleThe Motivator 2013 Archives
The 2013 Motivator Archives: MSAA’s 48-plus page magazine highlights and explains many vital issues of importance to our readers affected by MS.
Read News ArticleThe Multiple Sclerosis Association of America to Ring the Nasdaq Opening Bell
The Multiple Sclerosis Association of America (MSAA) is honored to ring the Nasdaq Stock Market Opening Bell on Friday, March 11, 2016 at Nasdaq MarketSite in recognition of Multiple Sclerosis Awareness Month. MSAA President & CEO Gina Ross Murdoch will ring the bell to open the market accompanied by members of the MS community.
Read News ArticleMSAA Art Showcases
MSAA is very proud to present our MSAA Art Showcases – celebrating the work of artists affected by MS. We have received many wonderful submissions over the years from across […]
Read News Article2016 MSAA MS Ability Art Showcase Artist of the Month
View MSAA’s 2016 MS Ability Art Showcase Artist of the Month for People Living with Multiple Sclerosis.
Read News Article